{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:38:33Z","timestamp":1777937913276,"version":"3.51.4"},"reference-count":10,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1177\/13524585251326843","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T01:08:22Z","timestamp":1742260102000},"page":"381-383","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Toward equity in MS care: A roadmap for accessible treatment"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4756-9889","authenticated-orcid":false,"given":"Jorge","family":"Correale","sequence":"first","affiliation":[{"name":"Department of Neurology, Fleni, Buenos Aires, Argentina"},{"name":"Institute of Biological Chemistry and Biophysics (IQUIFIB), CONICET, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70064-8"},{"key":"e_1_3_2_4_2","unstructured":"Atlas of MS 3rd edition https:\/\/www.msif.org\/wp-content\/uploads\/2020\/12\/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf (accessed 20 February 2025)."},{"issue":"4","key":"e_1_3_2_5_2","first-page":"465","article-title":"MS recommendations for essential medicines for multiple sclerosis in low-resource settings","volume":"31","author":"Saylor D","year":"2025","unstructured":"Saylor D, Rijke N, McDonell J, et al. MS recommendations for essential medicines for multiple sclerosis in low-resource settings. Mult Scler 2025; 31(4): 465\u2013474.","journal-title":"Mult Scler"},{"key":"e_1_3_2_6_2","unstructured":"Multisource (generic) pharmaceutical products: Guidelines on registration requirements to establish interchangeability https:\/\/www.who.int\/docs\/default-source\/medicines\/norms-and-standards\/guidelines\/regulatory-standards\/trs1003-annex6-who-multisource-pharmaceutical-products-interchangeability.pdf (accessed 20 February 2025)."},{"key":"e_1_3_2_7_2","unstructured":"Biosimilar medicines: Marketing authorization https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/marketing-authorisation\/biosimilar-medicines-marketing-authorisation (accessed 20 February 2025)."},{"key":"e_1_3_2_8_2","unstructured":"What is the approval process for generic drugs? https:\/\/www.fda.gov\/drugs\/generic-drugs\/what-approval-process-generic-drugs (accessed 20 February 2025)."},{"key":"e_1_3_2_9_2","unstructured":"WHO endorses landmark public health decisions on Essential Medicines for Multiple Sclerosis https:\/\/www.who.int\/news\/item\/26-07-2023-who-endorses-landmark-public-health-decisions-on-essential-medicines-for-multiple-sclerosis (accessed 20 February 2025)."},{"key":"e_1_3_2_10_2","article-title":"The economic burden of multiple sclerosis in the United States: Estimate of direct and indirect costs","volume":"98","author":"Bruce B","year":"2022","unstructured":"Bruce B, Cintina N, LaRocca N, et al. The economic burden of multiple sclerosis in the United States: Estimate of direct and indirect costs. Neurology 2022; 98: e1810\u2013e1817.","journal-title":"Neurology"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-021-01118-x"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585251326843","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13524585251326843","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585251326843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:17:59Z","timestamp":1777695479000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13524585251326843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1177\/13524585251326843"],"URL":"https:\/\/doi.org\/10.1177\/13524585251326843","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]}}}